OTLK insider transaction filings
Outlook Therapeutics, Inc. — 24 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-14. Screen OTLK transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | Jahr Robert Charles — Chief Executive Officer, Director | Purchase (P): 151,515 · Purchase (P): 151,515 (derivative) | EDGAR |
| 2026-08-14 | 4 | Sukhtian Ghiath M. — Director, 10% owner GMS Ventures & Investments — Director, 10% owner | Purchase (P): 2,525,252 @ $0.99 · Purchase (P): 2,525,252 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | KENYON LAWRENCE A — Chief Financial Officer, Director | Purchase (P): 101,010 · Purchase (P): 101,010 (derivative) | EDGAR |
| 2026-07-29 | 4 | Sukhtian Faisal Ghiath — Director | Purchase (P): 95,398 @ $1.05 | EDGAR |
| 2026-07-23 | 4 | Jahr Robert Charles — Chief Executive Officer, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | KENYON LAWRENCE A — Chief Financial Officer, Director | Grant/award (A): 210,078 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Haddadin Yezan Munther — Director | Purchase (P): 29,000 @ $0.83 | EDGAR |
| 2026-06-01 | 4 | Sukhtian Ghiath M. — Director, 10% owner GMS Ventures & Investments — Director, 10% owner | Purchase (P): 8,539,709 @ $0.59 · Code (H): 3,458,571 (derivative) · Purchase (P): 3,458,571 (derivative) · Code (H): 3,458,571 (derivative) · Purchase (P): 3,458,571 (derivative) · Code (H): 8,571,428 (derivative) · +1 more | EDGAR |
| 2026-05-27 | 4 | Haddadin Yezan Munther — Director | Purchase (P): 34,000 @ $0.44 | EDGAR |
| 2026-05-27 | 4 | Sukhtian Faisal Ghiath — Director | Purchase (P): 122,174 @ $0.41 | EDGAR |
| 2026-05-27 | 4 | THURMAN RANDY H — Director | Purchase (P): 5,000 @ $0.43 | EDGAR |
| 2026-05-27 | 4 | HILZINGER KURT J — Director | Purchase (P): 400,000 @ $0.44 | EDGAR |
| 2025-10-03 | 4 | Huang Andong — Director | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 53,316 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Haller Julia A — Director | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 58,648 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Haddadin Yezan Munther — Director | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 95,969 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Sukhtian Faisal Ghiath — Director | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 117,296 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Auffarth Gerd — Director | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 58,648 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Gangolli Julian S — Director | Grant/award (A): 286,734 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | THURMAN RANDY H — Director | Grant/award (A): 286,734 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | HILZINGER KURT J — Director | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 90,638 (derivative) @ $0 | EDGAR |
| 2025-07-09 | 4 | Jahr Robert Charles — Chief Executive Officer | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-05-28 | 4 | Sukhtian Ghiath M. — Director, 10% owner GMS Ventures & Investments — Director, 10% owner | Grant/award (A): 4,285,714 @ $1.40 · Grant/award (A): 8,571,428 (derivative) | EDGAR |
| 2025-03-12 | 4/A | Sukhtian Ghiath M. — Director, 10% owner GMS Ventures & Investments — Director, 10% owner | Option exercise (M): 3,458,571 @ $2.51 | EDGAR |
| 2025-02-06 | 4 | Sukhtian Faisal Ghiath — Director | Grant/award (A): 12,323 (derivative) @ $0 | EDGAR |
Recent 8-K events — Outlook Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-06-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OTLK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →